https://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 14:29:41 +0200Tue, 27 Feb 2024 13:00:00 +0100https://www.ema.europa.eu/en/medicines/human/EPAR/naveruclifHuman medicines European public assessment report (EPAR): Naveruclif, paclitaxel, Date of authorisation: 05/01/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/naveruclifTue, 27 Feb 2024 13:00:00 +0100Human medicinehttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6173-en.pdfNaveruclif : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6173-en.pdfTue, 27 Feb 2024 12:48:26 +0100Human medicine